Protective Effects of Rutaecarpine in Cardiac Anaphylactic Injury is Mediated by CGRP

Abstract

Previous investigations have indicated that rutaecarpine activates the vanilloid receptor to evoke calcitonin gene-related peptide (CGRP) release. CGRP has been shown to alleviate cardiac anaphylactic injury. In the present study, the effect of rutaecarpine on cardiac anaphylaxis was examined. Challenge of presensitized guinea-pig hearts with a specific antigen caused marked decreases in coronary flow (CF), left ventricular pressure (LVP) and its derivatives (± dp/dt_max), an increase in heart rate, and prolongation of the P-R interval. Rutaecarpine (0.3 or 1 μM) markedly increased the content of calcitonin gene-related peptide (CGRP) in the coronary effluent and decreased the content of tumor necrosis factor-α (TNF-α) in myocardial tissues concomitantly with a significant improvement of cardiac function and alleviation of the extension of the P-R interval. Rutaecarpine at the concentration of 1 μM also inhibited the sinus tachycardia. The protective effects of rutaecarpine on cardiac anaphylaxis were abolished by CGRP_{8 - 37}, a selective CGRP receptor antagonist. These results suggest that the protective effects of rutaecarpine on cardiac anaphylactic injury are related to inhibition of TNF-α production by stimulation of CGRP release.

Cardiac anaphylaxis - calcitonin gene-related peptide (CGRP) - rutaecarpine - tumor necrosis factor-α (TNF-α) - guinea-pig

References

• 1 Dai W, Zhou F W, Song Q J, Li Y J, Deng H W, Xiong X M. Protective effects of calcitonin gene-related peptide on guinea-pig cardiac anaphylaxis.  Naunyn Schmiedebergs Arch Pharmacol. 2000;  361 161-5
• 2 Rubin L E, Levi R. Protective role of bradykinin in cardiac anaphytaxis: coronary vasodilating and antirhythmic activities mediated by autocrine/paracrine mechanisms.  Circ Res. 1995;  76 434-40
• 3 Schuligoi R, Amann R, Donnerer J, Peskat B A. Release of calcitonin gene-related peptide in cardiac anaphylaxis.  Naunyn Schmiedebergs Arch Pharmacol. 1997;  355 224-9
• 4 Frangogiannis N G, Lindsey M L, Michael L H, Youker K A., Bressler R B, Mendoza L H, Spengler R N, Smith C W, Entman M L. Resident cardiac mast cells degranulate and release preformed TNF-a initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion.  Circulation. 1998;  98 699-710
• 5 Edmunds N J, Lal H, Woodward B. Effects of tumour necrosis factor-alpha on left ventricular function in the rat isolated perfused heart: possible mechanisms for a decline in cardiac function.  Br J Pharmacol. 1999;  126 189-96
• 6 Kwon O, Lee E, Moon T C, Jung H, Lin C X, Nam K S, Baek S H, Min H K, Chang H W. Expression of cyclooxygenase-2 and pro-inflammatory cytokines induced by 2,2′,4,4′,5,5′-hexachlorobiphenyl (PCB153) in human mast cells requires NF-kappaB activation.  Biol Pharm Bull. 2002;  25 1165-8
• 7 Retter A S, Frishman W H. The role of tumor necrosis factor in cardiac disease.  Heart Dis. 2001;  3 319-25
• 8 Hu C P, Xiao L, Deng H W, Li Y J. The cardioprotection of rutaecarpine is mediated by endogenous calcitonin related-gene peptide through activation of vanilloid receptors in guinea-pig hearts.  Planta Med. 2002;  68 705-9
• 9 Peng J, Xiao L, Ye F, Deng H W, Li Y J. Inhibition of cardiac tumor necrosis factor-α production by CGRP-mediated ischemia preconditioning in isolated rat heart.  Eur J Pharmacol. 2000;  407 303-8
• 10 Sheen W S, Tsai I L, Teng C M, Ko F N, Chen I S. Indolopyridoquinazoline alkaloids with antiplatelet aggregation activity from Zanthoxylum integrifoliolum .  Planta Med. 1996;  62 175-6
• 11 Hu C P, Xiao L, Deng H W, Li Y J. The depressor and vasodilator effects of rutaecarpine are mediated by calcitonin gene-related peptide.  Planta Med. 2003;  69 125-9
• 12 Rang W Q, Du Y H, Hu C P, Ye F, Tan G S, Deng H W, Li Y J. Protective effects of calcitonin gene-related peptide-mediated evodiamine on guinea-pig cardiac anaphylaxis.  Naunyn Schmiedebergs Arch Pharmacol. 2003;  367 306-11
• 13 Mitsuhata H, Saitoh J, Hasome N, Takeuchi H, Horiguchi Y, Shimizu R. Nitric oxide synthase inhibition is detrimental to cardiac function and promotes bronchospasm in anaphylaxis in rabbits.  Shock. 1995;  4 143-8
• 14 Marone G, de Crescenzo G, Florio G, Granata F, Dente V, Genovese A. Immunological modulation of human cardiac mast cells.  Neurochem Res. 1999;  24 1195-202
• 15 Bozkurt B, Kribbs S B, Clubb FJ J r, Michael L H, Didenko V V, Hornsby P J, Seta Y, Oral H, Spinale F G, Mann D L. Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats.  Circulation. 1998;  97 1382-91
• 16 Meldrum D R, Dinarello C A, Shames B D, Cleveland JC J r, Cain B S, Banerjee A, Meng X, Harken A H. Ischemic preconditioning decreases postischemic myocardial tumor necrosis factor-alpha production. Potential ultimate effector mechanism of preconditioning.  Circulation. 1998;  98(19 Suppl) II214 - 8; discussion II218 - 9
• 17 Millet I, Vegnery A. The neuropeptide calcitonin gene-related peptide inhibits TNF-alpha but poorly induces IL-6 production by fetal rat.  Osteoblasts Cytokine. 1997;  9 999-1007
• 18 Li Y, Fiscus R R, Wu J, Yang L, Wang X. The antiproliferative effects of calcitonin gene-related peptide in different passages of cultured vascular smooth muscle cells.  Neuropeptides. 1997;  31 503-9
• 19 Zhou Z H, Deng H W, Li Y J. Improvement of preservation with cardioplegic solution by nitroglycerin-induced delayed preconditioning is mediated by calcitonin gene-related peptide.  Int J Cardiol. 2001;  81 211-8